Bill Doyle: Treating cancer with electric fields
Bill Doyle: Elektrische Felder zur Krebsbehandlung
With his company Novocure, Bill Doyle works to bring breakthrough medical technologies to doctors and patients. Full bio
Double-click the English transcript below to play the video.
kommt mit Krebs in Berührung —
ein Familienmitglied,
Tumortherapiefelder funktionieren,
elektrisches Feld vorzustellen,
im Weltall vorstellen.
in drei Dimensionen,
das Erdgravitationsfeld eintreten,
angezogen zu werden.
dreidimensionalen Sequenz,
Krebsarten angewendet
für Patienten weiterzuentwickeln.
waren wieder gewachsen.
Radsport-Champion.
"Chemo-Schädel" auf.
dass im 6. Monat
Chemotherapieformen
einen auf dem Rücken
nebeneinander über der Leber.
in die Klinik musste.
und Tumortherapiefeldern.
macht gerade eine Studie,
zusammen mit Bestrahlung wirken
ABOUT THE SPEAKER
Bill Doyle - EngineerWith his company Novocure, Bill Doyle works to bring breakthrough medical technologies to doctors and patients.
Why you should listen
Bill Doyle is the executive chair of Novocure, a company commercializing a new therapeutic modality for solid tumors using low-intensity electric fields. Recently, Novocure received FDA approval for its first indication, recurrent Glioblastoma Multiforme (GBM), the most virulent form of brain cancer; it is now conducting additional clinical trials.
In 2002, Doyle co-founded medical device venture firm WFD Ventures, which provides financing and business-building expertise to medical device companies with the potential to make a major impact on patient care, working with entrepreneurs, doctors and scientists to improve medical outcomes and maximize the potential of their innovations.
A graduate of MIT, Doyle stablished the MIT FIRST Scholarship for FIRST Robotics Competition participants admitted to MIT.
Watch Jay Walker's onstage Q&A with Bill Doyle >>
Bill Doyle | Speaker | TED.com